Abstract

Nicotinamide-Adenine Dinucleotide (NADH) in Parkinson's Disease and Alzheimer's Disease

Author(s): Glasnapp Andrew, Schaefer Erin

Issue: Jul/Aug 2000 - Compounding for Hospice and Cancer Patients

Page(s): 276-279

Download in electronic PDF format for $75

Abstract

Nicotinamide-adenine dinucleotide (NADH) is currently being tested as a promising new therapy in the treatment of Parkinson’s and Alzheimer’s disease. The authors discuss some of these studies, in addition to providing figures showing the synthesis of dopamine and the Kreb’s cycle and providing tables showing results of the Birkmayer Parkinison’s Disease Study and the Mini-Mental State Examination. They also provide a formulation for NADH Capsules.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jul/Aug 2000 Pg. 276-279	Nicotinamide-Adenine Dinucleotide (NADH) in Parkinson's Disease and Alzheimer's Disease Author(s): Glasnapp Andrew, Schaefer Erin
Jul/Aug 2003 Pg. 288-291	Basics of Compounding for Raynaud's Disease Author(s): Glasnapp Andrew
May/Jun 2002 Pg. 171-176	Estrogen Replacement Therapy in the Treatment of Alzheimer's Disease Author(s): Osburn Jennifer
May/Jun 2003 Pg. 188-191	Treating Canine Hepatic Disease Author(s): Davidson Gigi S
Jan/Feb 1998 Pg. 24-29	Estrogen in the Treatment and Prevention of Alzheimer's Disease Author(s): Paganini-Hill Annlia, Henderson Victor W
Mar/Apr 2010 Pg. 108-111	Coenzyme Q10 Supplementation in the Treatment of Heart Disease Author(s): Bramwell Bethany L
Mar/Apr 2018 Pg. 149	Levodopa and Carbidopa Rectal Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 278	NADH Capsules Author(s): Glasnapp Andrew, Schaefer Erin
Jul/Aug 1998 Pg. 302	Nicotinamide 4% Topical Gel Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 293-296	Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases Author(s): Harrington Amy, Williams LaVonn
May/Jun 2004 Pg. 169-172	Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 1 Author(s): Davidson Gigi S
Jul/Aug 2004 Pg. 277-283	Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 2 Author(s): Davidson Gigi S
Sep/Oct 2013 Pg. 380-383	Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease Author(s): McElhiney Linda F
Nov/Dec 2012 Pg. 505	Dopamine Hydrochloride 80-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 382-394	Conservative Management of Chronic Kidney Disease in Cats: Recommendations for Veterinarians and Compounding Pharmacists Author(s): Meadows Richard L, Muller George
Mar/Apr 2011 Pg. 124-128	Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease Author(s): Corsini Lindsay, Williams LaVonn A
Jan/Feb 2012 Pg. 34-41	Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension Author(s): Helms Scott R, Fox Samantha, Mixon William, Vail Jane
Mar/Apr 2005 Pg. 117-119	Combating Cardiovascular Disease With Compounded Medications. Part 1: Combination Cardiac Medicines to Control Blood Pressure Author(s): Harrington Catherine A, Cauffield Jacintha
Mar/Apr 2001 Pg. 92-94	Feline Ophthalmic Disease: Feline Herpesvirus and Systemic Hypertension Author(s): Davidson Michael G
Jan/Feb 2002 Pg. 16-18	Compounding for Diseases of the Oral Cavity: A discussion with Stu Sommerville, RPh Author(s): Vail Jane